
News|Podcasts|June 19, 2021
OncView™ Podcast: Management of Relapsed/Refractory Follicular Lymphoma
Author(s)Matthew Fowler
This special edition of the “Oncology Peer Review On-The-Go” podcast details treatment options and considerations for relapsed/refractory follicular lymphoma.
Advertisement
As part of its OncView™ video series, CancerNetwork® spoke with Sameh Gaballa, MD, of the Moffit Cancer Center, about current and future treatment options and considerations for patients with relapsed/refractory follicular lymphoma (R/R FL).
In the video series, Gaballa discussed the following:
Treatment Options in Relapsed/Refractory Follicular Lymphoma Considerations for Treatment Selection in R/R FL Third-Line Therapy in Follicular Lymphoma Tazemetostat for Relapsed/Refractory Follicular Lymphoma R/R FL: The Role of PI3K Inhibitors Unmet Needs and Looking Ahead in Follicular Lymphoma
To watch more videos in CancerNetwork®’s OncView™ series, visit
Newsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on CancerNetwork
1
Modifiable Risk Factors Suggest Potential for Improving Cancer Prevention
2
2026 Tandem Meetings: What’s the Latest Research in Multiple Myeloma?
3
Barriers to CAR T-Cell Referral and Center Access in Multiple Myeloma
4
Dato-DXd Receives Priority Review in Unresectable/Metastatic TNBC
5



































